-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Harnessing the Power of Culture to Forge the Soul of Industry | MIIT Industrial Culture Development Center Conducts Research Visit to Shijiazhuang Sihua Pharmaceutical Group
Category:
发布时间：2024-08-02
【概要描述】
On August 1, a delegation led by Zhu Yongli, Deputy Director of the Industrial Culture Development Center of the Ministry of Industry and Information Technology, and Fan Rui, Deputy Director of the Brand Building Promotion Division, conducted a research visit to Shijiazhuang Sihua Pharmaceutical Group on the topic of industrial culture development and promotion. Gao Peixuan, Director of the Science and Technology Division of the Hebei Provincial Department of Industry and Information Technology, along with group leaders Shi Jianhui, Sun Lijie, Tian Pengmei, and others, accompanied the delegation for discussions and exchanges.
On August 1, a delegation led by Zhu Yongli, Deputy Director of the Industrial Culture Development Center of the Ministry of Industry and Information Technology, and Fan Rui, Deputy Director of the Brand Building Promotion Division, conducted a research visit to Shijiazhuang Sihua Pharmaceutical Group on the topic of industrial culture development and promotion. Gao Peixuan, Director of the Science and Technology Division of the Hebei Provincial Department of Industry and Information Technology, along with group leaders Shi Jianhui, Sun Lijie, Tian Pengmei, and others, accompanied the delegation for the briefing and discussion.
During the research visit, Zhu Yongli and his delegation toured the R&D Center’s laboratory building and the intelligent intravenous infusion production workshop at Shijiazhuang Sihua Pharmaceutical Group, conducting on-site inspections of the company’s development, brand cultivation, and infrastructure construction. They gained a detailed understanding of the company’s evolutionary journey, its achievements in innovation and business development, and the effectiveness of its branding efforts.
During the symposium, Zhu Yongli provided a detailed overview of the Industrial Culture Development Center under the Ministry of Industry and Information Technology and its core functions, while expressing full recognition of the Group’s comprehensive industrial-chain development strategy, its efforts to build smart factories, and its brand-development philosophy. He noted that Shijiazhuang Sihua Pharmaceutical Group, as a leading pharmaceutical enterprise in Hebei Province, places great emphasis on cultivating and promoting industrial culture. Leveraging its own developmental trajectory and deep-rooted corporate culture, the Group has continuously strengthened the integration and optimization of all elements of brand building, actively fostering an integrated “pharmaceuticals-plus-brand” development model that has significantly enhanced the company’s influence within the industry. He encouraged the company to inherit and carry forward the spirit of industry, further deepen the cultivation of brand culture, quality culture, and institutional culture, and use these as key pillars for advancing new-style industrialization and industrial culture, thereby harnessing brand culture to power and energize the company’s drive toward new-style industrialization.
After listening to a briefing on the Industrial Culture Development Center of the Ministry of Industry and Information Technology’s recent key initiatives, the Group’s leadership stated that industrial culture has always been integral to brand building. Moving forward, under the guidance of the Center, the Group will leverage the new trends and characteristics of digital transformation to further strengthen the alignment between industrial culture and brand development in a more targeted manner, with the aim of actively cultivating a “golden brand” for China’s pharmaceutical manufacturing industry and helping Chinese brands expand internationally and gain global recognition.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091